News of the WeekU.S. Science Policy

Cancer Institute Director Tapped for FDA

+ See all authors and affiliations

Science  24 Mar 2006:
Vol. 311, Issue 5768, pp. 1692
DOI: 10.1126/science.311.5768.1692a

You are currently viewing the summary.

View Full Text

Summary

The National Cancer Institute will be getting a new leader following the nomination last week of its controversial director, Andrew von Eschenbach, to head the U.S. Food and Drug Administration. As Science went to press, federal officials said von Eschenbach would step down "soon." (Read more.)

Related Content